FASN and neoplasm: Additionally, de novo lipid synthesis is frequently hyperactive in RCC, driven by elevated expression of fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC), leading to lipid accumulation that contributes to membrane biogenesis and signaling cascades involved in tumor progression and drug resistance [10, 13].